Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Klinger

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Perception|January 1, 1978
Apparent improvement of TV picture quality through narrow pupils independent of overall quantal flux reductionJ D Klinger
Infection|January 1, 1988
Isolation of Listeria: a review of procedures and future prospectsJ D Klinger
Diagnostic Microbiology and Infectious Disease|March 1, 1985
Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patientsJ D Klinger, M J Thomassen
The Journal of Pediatrics|May 1, 1986
Pseudomonas cepacia: biology, mechanisms of virulence, epidemiologyD A Goldmann, J D Klinger
The Journal of Antimicrobial Chemotherapy|May 1, 1985
Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosisS C Aronoff, J D Klinger
Antibiotics and Chemotherapy|January 1, 1987
Biological effects of Pseudomonas aeruginosa phenazine pigmentsR U Sorensen, J D Klinger
Antimicrobial Agents and Chemotherapy|February 1, 1984
In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosisS C Aronoff, J D Klinger
Journal of Ethnopharmacology|July 1, 1985
Some visual effects caused by the beverage kavaL F Garner, J D Klinger
The Journal of Antimicrobial Chemotherapy|June 1, 1985
In-vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patientsJ D Klinger, S C Aronoff
Journal of General Microbiology|June 1, 1976
Isolation and characterization of mutants of Escherichia coli K12 resistant to the new aminoglycoside antibiotic, amikacinR Hull, J D Klinger, E E Moody
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Perception|January 1, 1978
Apparent improvement of TV picture quality through narrow pupils independent of overall quantal flux reductionJ D Klinger
Infection|January 1, 1988
Isolation of Listeria: a review of procedures and future prospectsJ D Klinger
Diagnostic Microbiology and Infectious Disease|March 1, 1985
Occurrence and antimicrobial susceptibility of gram-negative nonfermentative bacilli in cystic fibrosis patientsJ D Klinger, M J Thomassen
The Journal of Pediatrics|May 1, 1986
Pseudomonas cepacia: biology, mechanisms of virulence, epidemiologyD A Goldmann, J D Klinger
The Journal of Antimicrobial Chemotherapy|May 1, 1985
Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosisS C Aronoff, J D Klinger
Antibiotics and Chemotherapy|January 1, 1987
Biological effects of Pseudomonas aeruginosa phenazine pigmentsR U Sorensen, J D Klinger
Antimicrobial Agents and Chemotherapy|February 1, 1984
In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosisS C Aronoff, J D Klinger
Journal of Ethnopharmacology|July 1, 1985
Some visual effects caused by the beverage kavaL F Garner, J D Klinger
The Journal of Antimicrobial Chemotherapy|June 1, 1985
In-vitro activity of ciprofloxacin and other antibacterial agents against Pseudomonas aeruginosa and Pseudomonas cepacia from cystic fibrosis patientsJ D Klinger, S C Aronoff
Journal of General Microbiology|June 1, 1976
Isolation and characterization of mutants of Escherichia coli K12 resistant to the new aminoglycoside antibiotic, amikacinR Hull, J D Klinger, E E Moody
Pageof 5